Caricamento...

The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial

INTRODUCTION: Osteoporosis is a major health problem for postmenopausal women. Adjuvant hormonal therapy with aromatase inhibitors (AIs) in postmenopausal breast cancer patients further worsens bone loss. Bisphosphonates are able to prevent AI-induced bone loss, but limited data exists on their effe...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: van Londen, G. J., Perera, S., Vujevich, K. T., Sereika, S. M., Bhattacharya, R., Greenspan, S. L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2857766/
https://ncbi.nlm.nih.gov/pubmed/19853678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2009.10.019
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !